Novel mechanism of transcriptional regulation of cell matrix protein through CREB

Hyperactivation of Akt/mTOR and deficiency in tuberin increased the oxidative DNA damage in kidney cancer patients with diabetes

(2015) Samy L. Habib et al.   Oncotarget

The mTOR Pathway Controls Cell Proliferation by Regulating the FoxO3a Transcription Factor via SGK1 Kinase

(2014) Shunsuke Mori et al.   PLoS One

Alterations in tubular epithelial cells in diabetic nephropathy

(2013) Samy L. Habib   JOURNAL OF NEPHROLOGY

Analysis of colorectal cancers in British Bangladeshi identifies early onset, frequent mucinous histotype and a high prevalence of RBFOX1 deletion

(2013) Neel Sengupta et al.   Molecular Cancer

mTOR Signaling in Growth Control and Disease

(2012) Mathieu Laplante et al.   CELL

Tuberin Inhibits Production of the Matrix Protein Fibronectin in Diabetes

(2012) S. L. Habib et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Transcriptional regulation of gene expression during osmotic stress responses by the mammalian target of rapamycin

(2012) M. Carmen Ortells et al.   NUCLEIC ACIDS RESEARCH

Novel mechanism of regulation of the DNA repair enzyme OGG1 in tuberin-deficient cells

(2010) S. L. Habib et al.   CARCINOGENESIS

Not all substrates are treated equally: Implications for mTOR, rapamycin-resistance, and cancer therapy

(2010) Andrew Y. Choo et al.   CELL CYCLE

Control of fibroblast fibronectin expression and alternative splicing via the PI3K/Akt/mTOR pathway

(2010) Eric S. White et al.   EXPERIMENTAL CELL RESEARCH

The Role of the Mammalian Target Of Rapamycin (mTOR) in Renal Disease

(2009) W. Lieberthal et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Mechanism of Oxidative DNA Damage in Diabetes: Tuberin Inactivation and Downregulation of DNA Repair Enzyme 8-Oxo-7,8-Dihydro-2'-Deoxyguanosine-DNA Glycosylase

(2008) S. Simone et al.   DIABETES